STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 108 filers reported holding STOKE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 3,355,466 | $69,401,000 | 4.13% |
| Cormorant Asset Management, LP | 1,788,394 | $38,433,000 | 2.34% |
| RA Capital Management | 1,119,963 | $24,068,000 | 1.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 346,380 | $7,384,000 | 1.14% |
| Redmile Group, LLC | 1,017,478 | $21,866,000 | 0.73% |
| GILDER GAGNON HOWE & CO LLC | 1,876,191 | $40,319,000 | 0.46% |
| Perceptive Advisors | 671,978 | $14,440,000 | 0.39% |
| Casdin Capital, LLC | 130,000 | $2,793,700,000 | 0.29% |
| OXFORD ASSET MANAGEMENT LLP | 116,196 | $2,497,000 | 0.06% |
| Granite Point Capital Management, L.P. | 17,000 | $365,000 | 0.06% |